Hall Laurie J Trustee Aerie Pharmaceuticals Inc Transaction History

Hall Laurie J Trustee

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Oct 11, 2022	SELL	$6.37 - $15.23 $1,433 - $3,426	-225 Reduced 31.69%	485 $7,000
Q1 2022 Apr 06, 2022	BUY	$5.64 - $9.8 $1,692 - $2,940	300 Added 73.17%	710 $6,000
Q3 2021 Oct 04, 2021	SELL	$11.32 - $16.63 $2,943 - $4,323	-260 Reduced 38.81%	410 $5,000
Q4 2020 Jan 25, 2021	BUY	$9.12 - $14.49 $2,462 - $3,912	270 Added 67.5%	670 $9,000
Q3 2020 Oct 09, 2020	BUY	$10.46 - $14.46 $2,092 - $2,892	200 Added 100.0%	400 $5,000

Q4 2019 Feb 12, 2020	BUY	$17.72 - $25.1 $708 - $1,004	40 Added 25.0%	200 $5,000
Q3 2019 Oct 25, 2019	BUY	$18.41 - $28.0 $2,945 - $4,480	160 New	160 $3,000

2.4M

Ticker AERI
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 49,390,500
Description
Aerie Pharmaceuticals, Inc., a pharmaceutical company, focuses on the discovery, development, and commercialization of ophthalmic therapies for open-angle glaucoma, dry eye, diabetic macular edema, and wet age-related macular degeneration in the United States. Its products include Rhopressa, a once-daily eye drop to reduce elevated intraocular p...

Get notified when there are updates to the investment portfolio of Hall Laurie J Trustee, based on Form 13F filings with the SEC.

Stay updated on Hall Laurie J Trustee with notifications on news.